欧盟限制中企参与医疗器械招标，中方发声：典型的“双标”

Core Points - The European Commission has decided to restrict Chinese companies from participating in medical device tenders valued over 5 million euros, marking the first ban since the implementation of the International Procurement Instrument (IPI) in 2022 [1] - The ban is a response to China's long-standing exclusion of EU-produced medical devices from government procurement, aiming to encourage China to treat EU enterprises with the same openness [1] Group 1 - The EU medical technology market is approximately 150 billion euros in 2023, with government procurement accounting for 70% of this market [1] - Contracts exceeding 5 million euros represent only 4% of the total number of tenders but account for about 60% of the total value [1] - The ban will cover various medical devices, including imaging equipment, artificial organs, and medical clothing [1] Group 2 - The ban may escalate trade tensions between the EU and China, following previous tariff measures on electric vehicles and countermeasures on EU brandy [2] - The EU aims to create a fair competitive environment for its enterprises while remaining committed to dialogue with China to resolve these issues [2] - Both parties have agreed to work together to prepare for important economic agendas and promote stable and healthy development of EU-China economic relations [2]